Login

ST JUDE MEDICAL, LLC SEC Filings

Filed On Filing
07 Mar 2017 425
21 Feb 2017 425
14 Feb 2017 SC 13G/A
10 Feb 2017 SC 13G/A
27 Jan 2017 SC 13G/A
17 Jan 2017 15-12B
12 Jan 2017 EFFECT
12 Jan 2017 EFFECT
10 Jan 2017 S-8 POS
10 Jan 2017 S-8 POS
10 Jan 2017 S-8 POS
10 Jan 2017 S-8 POS
10 Jan 2017 S-8 POS
06 Jan 2017 Form 4: Andrade Lisa, VP and Chief Marketing Officer

Returned 10,302 shares to the issuer · Disposed of 86,222 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 3,687 Restricted Stock Units (Disposition to Issuer)

06 Jan 2017 Form 4: Essig Stuart, Director

Returned 48,777 shares to the issuer · Disposed of 47,950 Stock Options (Right to Buy) (Disposition to Issuer)

06 Jan 2017 Form 4: Hill Barbara B, Director

Returned 32,863 shares to the issuer · Disposed of 47,950 Stock Options (Right to Buy) (Disposition to Issuer)

06 Jan 2017 Form 4: Yarno Wendy L, Director

Returned 30,240 shares to the issuer · Disposed of 47,950 Stock Options (Right to Buy) (Disposition to Issuer)

06 Jan 2017 Form 4: Fain Eric S, Group President

Returned 130,716 shares to the issuer · Disposed of 906,428 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 15,548 Restricted Stock Units (Disposition to Issuer)

06 Jan 2017 Form 4: Starks Daniel J, Director

Returned 6,315,961 shares to the issuer · Disposed of 2,423,033 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 28,009 Restricted Stock Units (Disposition to Issuer)

06 Jan 2017 Form 4: Zurbay Donald, VP Finance and CFO

Returned 26,075 shares to the issuer · Disposed of 403,844 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 14,800 Restricted Stock Units (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support